Clinical Research Directory
Browse clinical research sites, groups, and studies.
Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes
Sponsor: University of Nottingham
Summary
Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs. The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
Official title: Surveying Experiences and Lifestyle Effects in Choosing Technology and Hybrid Closed Loop in Type 1 Diabetes
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2025-09
Completion Date
2026-02
Last Updated
2025-09-24
Healthy Volunteers
Not specified
Conditions
Locations (1)
University Hospitals of Derby and Burton
Derby, United Kingdom